Elanco Animal Health (ELAN) Interest Expenses (2018 - 2026)

Elanco Animal Health has disclosed Interest Expenses across 9 years of filings, most recently posting $57.0 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $57.0 million, up 42.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $237.0 million (up 13.4% YoY), and the FY2025 annual result was $220.0 million, down 6.38% from the prior year.
• Interest Expenses came in at $57.0 million for Q1 2026 at Elanco Animal Health, down from $80.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $80.0 million in Q4 2025 to a low of $40.0 million in Q1 2025.
• The 5-year median for Interest Expenses is $62.0 million (2022), against an average of $60.6 million.
• Peak annual rise in Interest Expenses reached 73.91% in 2025, while the deepest fall reached 39.39% in 2025.
• Elanco Animal Health's Interest Expenses stood at $62.0 million in 2022, then increased by 8.06% to $67.0 million in 2023, then plunged by 31.34% to $46.0 million in 2024, then surged by 73.91% to $80.0 million in 2025, then fell by 28.75% to $57.0 million in 2026.
• The last three Interest Expenses figures came in at $57.0 million (Q1 2026), $80.0 million (Q4 2025), and $52.0 million (Q3 2025), per Business Quant data.